-       Report 
- September 2024
-  120 Pages 
- Colombia 
   From       €7114EUR$7,995USD£6,263GBP 
          -       Report 
- September 2024
-  118 Pages 
- Brazil 
   From       €7114EUR$7,995USD£6,263GBP 
          -       Report 
- July 2024
-  331 Pages 
- Global 
   From       €8004EUR$8,995USD£7,046GBP 
          -       Report 
- March 2024
-  450 Pages 
- United States 
   From       €7114EUR$7,995USD£6,263GBP 
          -       Report 
- January 2022
-  367 Pages 
- China 
   From       €8004EUR$8,995USD£7,046GBP 
           -       Report 
- March 2021
-  584 Pages 
- United States 
   From       €7114EUR$7,995USD£6,263GBP 
          -       Report 
- August 2024
-  92 Pages 
- Global 
   From       €3500EUR$4,213USD£3,189GBP 
          -       Report 
- August 2023
-  121 Pages 
- Global 
   From       €3500EUR$4,213USD£3,189GBP 
              -       Book 
- April 2014
- North America 
                The Interbody Device market is a subset of the Orthopedic Devices market, which focuses on the treatment of musculoskeletal conditions. Interbody Devices are used to treat spinal conditions, such as degenerative disc disease, spinal stenosis, and spondylolisthesis. These devices are typically implanted between two vertebrae to provide stability and support to the spine. Interbody Devices are typically made of titanium or PEEK (polyetheretherketone) and come in a variety of shapes and    sizes.
Interbody Devices are used in a variety of spinal surgeries, including anterior lumbar interbody fusion (ALIF), posterior lumbar interbody fusion (PLIF), and transforaminal lumbar interbody fusion (TLIF). These devices are designed to provide stability and support to the spine, while also allowing for fusion of the vertebrae.
Some companies in the Interbody Device market include Medtronic, Stryker, DePuy Synthes, Zimmer Biomet, Globus Medical, and NuVasive. Show Less   Read more